Key Vaccine Innovations Throughout History

Preventing public health crises and lowering mortality rates, vaccines have revolutionized global health. With the latest mRNA vaccine technology ushering in a new era of vaccinology, there has been a renewed interest in vaccine development for researchers. In recognition of National Immunization Month, we reviewed some of the key vaccine innovations throughout history that protected people of all ages against serious diseases.

Travel Vaccines: Planning Responsibly for Safe, Healthy Travel

As more people become vaccinated against COVID-19, countries around the world are re-opening for travel and tourism. But it’s not just COVID-19 that patients need protection from. Depending on the planned destination, patients may also need additional travel vaccines. By providing pre-travel consultation and care, providers have a significant role to play in preparing patients for safe, healthy travel in the coming months.

Infant Immunizations: The First Step to Lifelong Immunity

With the highly anticipated return to in-person learning and play, infant immunizations are critical to preventing future outbreaks of vaccine preventable diseases for one of society’s most vulnerable age groups. As we inch towards a new normal and social activities resume, providers should emphasize the importance of infant immunizations to families who may have postponed their babies’ immunization appointments during the pandemic.

Playing Catch-Up with Adolescent Immunization Before the Return to In-Person School

As of late May 2021, The Centers for Disease Control and Prevention (CDC) has extended COVID-19 vaccine eligibility to include adolescents as young as 12 years old. The agency’s newest clinical guidance also approves the co-administration of COVID-19 vaccines along with other recommended vaccines. Providers have a tremendous opportunity over the next few months to help ensure that teen patients are up-to-date with their vaccinations, including the COVID-19 vaccine, before schools return to in-person learning this fall.

Navigating Vaccine Administration in the Shift to Telehealth

Stay-at-home orders and fear of contracting the coronavirus drove many patients to seek virtual care rather than visiting their physician in person. However, there are limitations to telehealth in circumstances for which in-person visits are more appropriate due to the requirement of physical presence to deliver a care service such as vaccinations. Providers should consider using telehealth to their advantage to bolster vaccine compliance.

Preparing for the 2021-2022 Flu Season: Lessons Learned from COVID-19

Although flu season generally runs from October through April, as noted by the Centers for Disease Control and Prevention (CDC), preparation is a year-round activity. The typical preparation providers and medical practices perform is routine and doesn’t vary much from year to year — except in 2020.

The COVID-19 pandemic added an unexpected complexity that upended typical flu season preparations but also provided some lessons learned for dealing with unusual public health circumstances. While we cannot predict what 2021 will bring, by examining the current flu season thus far, providers and practices can pick up a few principles to apply moving forward to better prepare for and adapt to future flu seasons.

Press Release: Atlantic Health Partners Announces Addition of Prevnar 13 to Program

Atlantic Health Partners, the nation’s premier buying group for physicians, health systems, physician organizations and medical practices, today announced the addition of Prevnar 13® to its vaccine program. Beginning January 1, 2021, Atlantic Health Partners’ members will have access to Pfizer’s pneumococcal 13-valent conjugate vaccine that protects against 13 strains of Streptococcus pneumoniae.

The HPV Vaccine: Expanding Its Role in Cancer Prevention

While the human papilloma virus (HPV) vaccine was first designed to prevent cervical cancer, its role in cancer prevention has expanded to cover six types of cancer. Most recently, the FDA approved the HPV vaccine to prevent oropharyngeal and other head and neck cancers. Explore the expanded benefits of the HPV vaccines and the impact these changes have on vaccine recommendations.